Skip to content

Author

Xiao-Xiang Guan

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Real-world efficacy and safety of neoadjuvant immunochemotherapy in patients with triple-negative breast cancer.

AIM To evaluate the real‑world efficacy and safety of adding programmed cell death protein 1 (PD-1) inhibitors to neoadjuvant chemotherapy in Chinese patients with triple‑negative breast cancer (TNBC). PATIENTS AND METHODS This single-center retrospective study enrolled 218 TNBC patients receiving neoadjuvant therapy...

Ruo-Xi Xu, Pin-Chao Fan, Yi-Qiu Liu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.